sb 203580 has been researched along with clobetasol in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (clobetasol) | Trials (clobetasol) | Recent Studies (post-2010) (clobetasol) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 1,532 | 389 | 593 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akama, T; Dong, C; Fan, XQ; Freund, YR; Jarnagin, K; Kimura, R; Liu, L; Lu, X; Nieman, JA; Plattner, JJ; Sales, M; Sharma, R; Singh, R; Virtucio, C; Wu, A; Zhang, YK | 1 |
1 other study(ies) available for sb 203580 and clobetasol
Article | Year |
---|---|
Structure-activity relationships of 6-(aminomethylphenoxy)-benzoxaborole derivatives as anti-inflammatory agent.
Topics: Animals; Anti-Inflammatory Agents; Benzoxazoles; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Half-Life; Humans; Interleukin-1beta; Interleukin-6; Kinetics; Leukocytes, Mononuclear; Lipopolysaccharides; Mice; Protein Binding; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2013 |